Patent Troll Legislation Gets Attention At Senate Hearing
This article was originally published in The Gray Sheet
Executive Summary
Biotechnology Industry Organization throws support behind Senate bill’s revisions to the inter partes review process, argues against provisions in House measure.
You may also be interested in...
Senate Bill Takes Targeted, MedTech-Supported Approach To Patent Trolls
The STRONG Patents Act, introduced this week, includes multiple provisions that device and biotech firms say would strengthen the patent system and appropriately take a targeted approach to patent trolls. But the tech industry favors stronger measures to fight trolls that device companies say would weaken the overall patent system.
The Patent Trolls Are Coming...To Medtech
For years medical device makers have largely avoided one of the technology world’s biggest headaches: patent “troll” litigation, but that’s about to change. What medtech needs to do to fight the trolls.
Medtronic Goes Trolling? Kyphon Patents Are Basis Of New Suits, But Not From Medtronic
Recently incorporated Orthophoenix, which shares the same Dallas address as IPNav, a company that provides “full-service patent monetization,” is suing six device firms for infringement of the Medtronic kyphoplasty patents it recently acquired.